Rapid HIV Testing and Counseling in Drug Abuse Treatment
- Conditions
- Substance-Related Disorders
- Registration Number
- NCT00809445
- Lead Sponsor
- University of Miami
- Brief Summary
This is a randomized controlled clinical trial in which adults receiving drug abuse treatment will be recruited to participate in a multi-center HIV testing and counseling study. The purpose of this study is to assess the relative effectiveness of three HIV testing strategies on increasing receipt of test results: (1) on-site HIV rapid testing with brief, participant-tailored prevention counseling, (2) on-site HIV rapid testing with information only, and (3) referral for off-site HIV testing. The study will also assess the effectiveness of the three testing strategies in reducing HIV risk behaviors.
- Detailed Description
This is a randomized controlled clinical trial in which individuals receiving drug abuse treatment will be recruited to participate in a multi-center HIV testing and counseling study. The purpose of this study is to assess the relative effectiveness of three HIV testing strategies on increasing receipt of HIV test results: (1) on-site HIV rapid testing with brief, participant-tailored prevention counseling, (2) on-site HIV rapid testing with information only, and (3) referral for off-site HIV testing. The study will also assess the effectiveness of the three testing strategies in reducing HIV sexual risk behaviors. Injection drug risk behavior will be a secondary outcome. Participants will complete a baseline assessment to report their demographics, HIV testing history and sexual and drug-using risk behaviors, and will be randomized to one of three groups. At one month post-randomization, participants will complete a follow-up assessment to determine whether or not they received their HIV test results. At six months post-randomization, participants will complete a follow-up assessment to assess any changes in their HIV sexual risk behaviors.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1281
- At least 18 years of age
- HIV-negative or HIV status unknown
- No receipt of results from HIV test initiated within last 12 months
- Be able to communicate in English
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Self-Report Receipt of HIV Test Results One month post-randomization The HIV testing primary outcome is self-reported receipt of HIV test results. This will be measured at one month post-randomization for all participants. We recognize that there are three potential HIV testing behaviors that could be evaluated in this study: acceptance of HIV testing, completion of HIV testing, and receipt of HIV testing results. Acceptance of testing refers to whether or not a participant would accept the offer of an HIV test. Completion of testing refers to whether or not a participant completes the HIV test. Receipt of HIV test results refers to whether or not a participant self-reports having received the results of the HIV test.
Number of Risky Sexual Behaviors Six months post-randomization The sexual risk behavior primary outcome is self-reported sexual risk behavior, which will be measured at baseline and six months post-randomization as the self-reported number of unprotected sex acts (vaginal or anal sex without a condom).
- Secondary Outcome Measures
Name Time Method Sharing of Needles Used in Drug Use Six months Change in sharing of needles. The number of individuals reporting needle sharing at baseline and 6-month follow-up were measured and the change in sharing of needles assessed.
Self-Report of Ever Having Been Tested 1 month post-randomization The HIV testing secondary outcomes are all binary (Yes/No). The below data represents self-reported completion of HIV test by 1 month.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (12)
La Frontera Center, Inc.
🇺🇸Tucson, Arizona, United States
Midwestern Connecticut Council on Alcoholism
🇺🇸Danbury, Connecticut, United States
Wheeler Clinic
🇺🇸Plainville, Connecticut, United States
Glenwood Life Counseling Center
🇺🇸Baltimore, Maryland, United States
Gibson Recover Centers
🇺🇸Cape Girardeau, Missouri, United States
The Life Link
🇺🇸Santa Fe, New Mexico, United States
Daymark Recovery Services, Inc.
🇺🇸Salisbury, North Carolina, United States
CODA
🇺🇸Portland, Oregon, United States
Addiction Medicine Services (Western Psychiatric Institute)
🇺🇸Pittsburgh, Pennsylvania, United States
Morris Village Alcohol and Drug Treatment Center
🇺🇸Columbia, South Carolina, United States
Scroll for more (2 remaining)La Frontera Center, Inc.🇺🇸Tucson, Arizona, United States